- Report
- November 2023
- 119 Pages
Global
From €5719EUR$5,950USD£4,904GBP
- Report
- December 2023
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- October 2023
- 172 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- September 2023
- 190 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- December 2018
- 155 Pages
Global
From €817EUR$850USD£701GBP
- Report
- April 2019
- 75 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- June 2018
- 92 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- April 2023
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Book
- November 2015
- 776 Pages
- Book
- October 2018
- 656 Pages
The Human Stem Cell market is a rapidly growing sector of the stem cell industry. It is focused on the development of stem cell-based therapies and products for the treatment of various diseases and conditions. These therapies and products are based on the use of human stem cells, which are capable of self-renewal and differentiation into various cell types. The Human Stem Cell market is driven by the increasing demand for stem cell-based therapies and products, as well as the growing awareness of the potential of stem cells in the treatment of various diseases and conditions.
The Human Stem Cell market is highly competitive, with a number of companies offering a range of products and services. These companies include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Pluristem Therapeutics, Inc. Show Less Read more
